TY - JOUR T1 - Interferon lambda 4 can directly activate human CD19<sup>+</sup> B cells and CD8<sup>+</sup> T cells JF - Life Science Alliance JO - Life Sci. Alliance DO - 10.26508/lsa.201900612 VL - 4 IS - 1 SP - e201900612 AU - Mairene Coto-Llerena AU - Marco Lepore AU - Julian Spagnuolo AU - Daniela Di Blasi AU - Diego Calabrese AU - Aleksei Suslov AU - Glenn Bantug AU - Francois HT Duong AU - Luigi M Terracciano AU - Gennaro De Libero AU - Markus H Heim Y1 - 2021/01/01 UR - https://www.life-science-alliance.org/content/4/1/e201900612.abstract N2 - Compared with the ubiquitous expression of type I (IFNα and IFNβ) interferon receptors, type III (IFNλ) interferon receptors are mainly expressed in epithelial cells of mucosal barriers of the of the intestine and respiratory tract. Consequently, IFNλs are important for innate pathogen defense in the lung and intestine. IFNλs also determine the outcome of hepatitis C virus (HCV) infections, with IFNλ4 inhibiting spontaneous clearance of HCV. Because viral clearance is dependent on T cells, we explored if IFNλs can directly bind to and regulate human T cells. We found that human B cells and CD8+ T cells express the IFNλ receptor and respond to IFNλs, including IFNλ4. IFNλs were not inhibitors but weak stimulators of B- and T-cell responses. Furthermore, IFNλ4 showed neither synergistic nor antagonistic effects in co-stimulatory experiments with IFNλ1 or IFNα. Multidimensional flow cytometry of cells from liver biopsies of hepatitis patients from IFNλ4-producers showed accumulation of activated CD8+ T cells with a central memory-like phenotype. In contrast, CD8+ T cells with a senescent/exhausted phenotype were more abundant in IFNλ4–non-producers. It remains to be elucidated how IFNλ4 promotes CD8 T-cell responses and inhibits the host immunity to HCV infections. ER -